Ceftizoxime
Kathryn Dzintars, Pharm.D., BCPS
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
No longer available in the U.S.
Lower respiratory tract infections
Urinary tract infections
Gonorrhea
including uncomplicated cervical and urethral
gonorrhea
Pelvic inflammatory disease
caused by
N. gonorrhoeae
,
E. coli
or
S. agalactiae
Intra-abdominal infections
(author’s comment: avoid in severe intra-abdominal infections)
Septicemia caused by
S. pneumoniae
, MSSA,
E. coli
,
Bacteroides
spp. including
B. fragilis
,
Klebsiella
spp. and
Serratia
spp.
(must confirm sensitivity)
Skin and skin-structure infections (not MRSA)
Bone and joint infections
Meningitis caused by
H. influenzae
(limited data with
S. pneumoniae
)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Septic arthritis, community-acquired
Genital ulcer adenopathy syndrome
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved